Yoshiaki Sato

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Radiation Induced

Severe Traumatic Brain Injury

Top Venues

Current issues in molecular biology

Antioxidants (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Kota Sato, Hironori Yoshino, Yoshiaki Sato, Manabu Nakano, Eichi Tsuruga
ΔNp63 Regulates Radioresistance in Human Head and Neck Squamous Carcinoma Cells. Current issues in molecular biology 45 (8) (2023)
Yoshiaki Sato, Masaru Yamaguchi, Ikuo Kashiwakura
An Analysis of the Serum Metabolomic Profile for the Radiomitigative Effect of the Thrombopoietin Receptor Agonist Romiplostim in Lethally Whole-Body-Irradiated Mice. Metabolites 12 (2) (2022)
Taichi Nyui, Hironori Yoshino, Tetsuya Nunota, Yoshiaki Sato, Eichi Tsuruga
cGAS Regulates the Radioresistance of Human Head and Neck Squamous Cell Carcinoma Cells. Cells 11 (9) (2022)
Masaru Yamaguchi, Yota Tatara, Eka Djatnika Nugraha, Yoshiaki Sato, Tomisato Miura, Masahiro Hosoda, Mukh Syaifudin, Shinji Tokonami, Ikuo Kashiwakura
Serum Proteomic and Oxidative Modification Profiling in Mice Exposed to Total Body X-Irradiation. Antioxidants (Basel, Switzerland) 11 (9) (2022)
Yoshiaki Sato, Hironori Yoshino, Ikuo Kashiwakura, Eichi Tsuruga
DAP3 Is Involved in Modulation of Cellular Radiation Response by RIG-I-Like Receptor Agonist in Human Lung Adenocarcinoma Cells. International journal of molecular sciences 22 (1) (2021)
Hironori Yoshino, Yoshiaki Sato, Manabu Nakano
KPNB1 Inhibitor Importazole Reduces Ionizing Radiation-Increased Cell Surface PD-L1 Expression by Modulating Expression and Nuclear Import of IRF1. Current issues in molecular biology 43 (1) (2021)
Masaharu Hazawa, Hironori Yoshino, Yuta Nakagawa, Reina Shimizume, Keisuke Nitta, Yoshiaki Sato, Mariko Sato, Richard W Wong, Ikuo Kashiwakura
Karyopherin-β1 Regulates Radioresistance and Radiation-Increased Programmed Death-Ligand 1 Expression in Human Head and Neck Squamous Cell Carcinoma Cell Lines. Cancers 12 (4) (2020)